Mrs. Carla Jo Chambers, M.ED, NBCC,LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 26 North Main Street, Suite 5, Jacobus, PA 17407 Phone: 717-817-2373 |
Elizabeth Reihm, MA Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 201 Ameda Dr, Jacobus, PA 17407 Phone: 717-805-2242 |
Mr. Glenn A Hennon Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 23 N Pleasant Ave, Jacobus, PA 17407 Phone: 717-227-9997 |
News Archive
Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2009. Full details of the Company's financial results are available in the Company's Form 10-K available at www.championsbiotechnology.com.
Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion, according to two studies conducted at the Center for Translational Medicine at Thomas Jefferson University. The studies will be presented at the American Heart Association Scientific Sessions 2009 in Orlando, Fla.
UBM Medica US announces that Neurology Times, a leading online community and information resource for neurologists and other healthcare providers, is featuring special coverage of multiple sclerosis in observance of MS Awareness Month.
Children born to mothers with polycystic ovarian syndrome, PCOS, are at an increased risk of developing autism spectrum disorders, according to a new epidemiological study from Sweden's Karolinska Institutet. The findings, which are published in the journal Molecular Psychiatry, support the notion that exposure to sex hormones early in life may be important for the development of autism in both sexes.
Lyme disease, if not treated promptly with antibiotics, can become a lingering problem for those infected. But a new study led by researchers from the University of Pennsylvania has some brighter news: Once infected with a particular strain of the disease-causing bacteria, humans appear to develop immunity against that strain that can last six to nine years.
› Verified 2 days ago